A detailed history of Met Life Investment Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 59,989 shares of FATE stock, worth $172,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,989
Previous 38,329 56.51%
Holding current value
$172,168
Previous $281,000 30.25%
% of portfolio
0.0%
Previous 0.0%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.26 - $7.08 $70,611 - $153,352
21,660 Added 56.51%
59,989 $196,000
Q1 2024

May 14, 2024

BUY
$3.54 - $8.35 $135,684 - $320,047
38,329 New
38,329 $281,000
Q2 2023

Apr 29, 2024

BUY
$4.76 - $6.59 $209,459 - $289,986
44,004 New
44,004 $209,000
Q1 2023

May 09, 2024

BUY
$4.24 - $11.12 $186,576 - $489,324
44,004 New
44,004 $251 Million
Q1 2022

May 10, 2024

BUY
$29.67 - $60.28 $1.31 Million - $2.65 Million
44,004 New
44,004 $1.71 Million
Q1 2022

Mar 22, 2023

BUY
$29.67 - $60.28 $463,979 - $942,658
15,638 Added 55.13%
44,004 $1.71 Million
Q1 2022

May 12, 2022

BUY
$29.67 - $60.28 $463,979 - $942,658
15,638 Added 55.13%
44,004 $1.71 Million
Q4 2021

Jun 21, 2023

SELL
$47.84 - $64.34 $748,121 - $1.01 Million
-15,638 Reduced 35.54%
28,366 $1.66 Million
Q3 2021

Jun 21, 2023

SELL
$59.27 - $95.73 $926,864 - $1.5 Million
-15,638 Reduced 35.54%
28,366 $1.68 Million
Q2 2021

Jun 21, 2023

SELL
$67.25 - $92.52 $1.05 Million - $1.45 Million
-15,638 Reduced 35.54%
28,366 $2.46 Million
Q1 2021

May 17, 2024

SELL
$72.16 - $117.4 $718,930 - $1.17 Million
-9,963 Reduced 25.99%
28,366 $2.34 Million
Q1 2021

Jun 26, 2023

SELL
$72.16 - $117.4 $1.13 Million - $1.84 Million
-15,638 Reduced 35.54%
28,366 $2.34 Billion
Q1 2021

Mar 22, 2023

SELL
$72.16 - $117.4 $15,153 - $24,654
-210 Reduced 0.73%
28,366 $2.34 Million
Q1 2021

May 14, 2021

SELL
$72.16 - $117.4 $15,153 - $24,654
-210 Reduced 0.73%
28,366 $2.34 Million
Q4 2020

May 24, 2024

SELL
$38.09 - $100.95 $64,105 - $169,898
-1,683 Reduced 5.56%
28,576 $2.6 Million
Q4 2020

Jun 22, 2023

SELL
$38.09 - $100.95 $587,652 - $1.56 Million
-15,428 Reduced 35.06%
28,576 $2.6 Million
Q4 2020

Mar 22, 2023

SELL
$38.09 - $100.95 $64,105 - $169,898
-1,683 Reduced 5.56%
28,576 $2.6 Million
Q4 2020

Feb 16, 2021

SELL
$38.09 - $100.95 $64,105 - $169,898
-1,683 Reduced 5.56%
28,576 $2.6 Million
Q3 2020

May 24, 2024

BUY
$30.41 - $40.5 $101,691 - $135,432
3,344 Added 12.42%
30,259 $1.21 Billion
Q3 2020

Jun 26, 2023

SELL
$30.41 - $40.5 $417,985 - $556,672
-13,745 Reduced 31.24%
30,259 $1.21 Million
Q3 2020

Mar 22, 2023

BUY
$30.41 - $40.5 $101,691 - $135,432
3,344 Added 12.42%
30,259 $1.21 Million
Q3 2020

Nov 13, 2020

BUY
$30.41 - $40.5 $101,691 - $135,432
3,344 Added 12.42%
30,259 $1.21 Million
Q2 2020

May 24, 2024

SELL
$20.21 - $35.23 $230,676 - $402,115
-11,414 Reduced 29.78%
26,915 $923 Million
Q2 2020

Jun 26, 2023

SELL
$20.21 - $35.23 $345,368 - $602,045
-17,089 Reduced 38.84%
26,915 $923,000
Q1 2020

Jul 12, 2023

SELL
$17.28 - $31.88 $295,297 - $544,797
-17,089 Reduced 38.84%
26,915 $597,000
Q4 2019

Jul 12, 2023

SELL
$13.39 - $20.73 $228,821 - $354,254
-17,089 Reduced 38.84%
26,915 $526,000
Q4 2019

Mar 22, 2023

BUY
$13.39 - $20.73 $48,940 - $75,768
3,655 Added 15.71%
26,915 $526,000
Q4 2019

Feb 14, 2020

BUY
$13.39 - $20.73 $48,940 - $75,768
3,655 Added 15.71%
26,915 $527,000
Q3 2019

Jul 12, 2023

SELL
$15.47 - $22.5 $320,909 - $466,740
-20,744 Reduced 47.14%
23,260 $361,000
Q3 2019

Mar 22, 2023

SELL
$15.47 - $22.5 $71,517 - $104,017
-4,623 Reduced 16.58%
23,260 $361,000
Q3 2019

Nov 14, 2019

SELL
$15.47 - $22.5 $71,517 - $104,017
-4,623 Reduced 16.58%
23,260 $361,000
Q2 2019

Jul 12, 2023

SELL
$15.61 - $20.44 $251,648 - $329,513
-16,121 Reduced 36.64%
27,883 $566,000
Q1 2019

Jul 13, 2023

SELL
$13.15 - $18.71 $211,991 - $301,623
-16,121 Reduced 36.64%
27,883 $489,000
Q4 2018

Jul 13, 2023

SELL
$11.48 - $16.98 $185,069 - $273,734
-16,121 Reduced 36.64%
27,883 $357,000
Q4 2018

Mar 22, 2023

SELL
$11.48 - $16.98 $91,093 - $134,736
-7,935 Reduced 22.15%
27,883 $357,000
Q4 2018

Feb 14, 2019

SELL
$11.48 - $16.98 $91,093 - $134,736
-7,935 Reduced 22.15%
27,883 $358,000
Q3 2018

Jul 13, 2023

SELL
$8.75 - $16.29 $183,102 - $340,884
-20,926 Reduced 47.55%
23,078 $375,000
Q3 2018

Mar 22, 2023

SELL
$8.75 - $16.29 $71,627 - $133,349
-8,186 Reduced 18.6%
35,818 $583,000
Q3 2018

Nov 14, 2018

BUY
$8.75 - $16.29 $111,475 - $207,534
12,740 Added 55.2%
35,818 $583,000
Q1 2018

May 15, 2018

BUY
$6.3 - $13.77 $145,391 - $317,784
23,078 New
23,078 $225,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $278M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.